In 2023, the mortality from Chronic Liver Diseases and Cirrhosis in the US stood at approximately 38,000 male deaths. Forecast data from 2024 to 2028 suggest a continuous increase in mortality, with values rising from 39.55 thousand to 45.8 thousand male deaths. The year-on-year growth rates are around 4% or slightly above each year, with a compound annual growth rate (CAGR) of around 3.75% over the five-year forecast period, indicating a significant upward trend.
Future trends to watch for include advancements in medical treatments and public health initiatives that could impact mortality rates. Lifestyle changes, policy implementations related to alcohol and viral hepatitis, and improved access to healthcare facilities are critical factors to monitor. Addressing these could potentially alter this upward trajectory by reducing prevalence and mortality associated with liver-related conditions.
